Surprising? Perhaps not. Long-chain fatty acid oxidation during human fetal development

Pediatric Research

Volumn 57, Issue 6, 2005, Pages 753-754

  Strauss, Arnold W ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; GLUCOSE; LONG CHAIN 3 HYDROXYACYL COENZYME A DEHYDROGENASE; LONG CHAIN FATTY ACID; OXIDOREDUCTASE; PROTEIN; TOXIN; TRIFUNCTIONAL PROTEIN; UNCLASSIFIED DRUG; VERY LONG CHAIN ACYL COENZYME A DEHYDROGENASE;

ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; GENE MUTATION; HEART; HELLP SYNDROME; HUMAN; LIVER; LIVER DISEASE; MATERNAL BLOOD; MITOCHONDRIAL RESPIRATION; MOTHER FETUS RELATIONSHIP; NOTE; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA;

FATTY ACIDS; FEMALE; FETAL DEVELOPMENT; HUMANS; LIPID METABOLISM, INBORN ERRORS; MATERNAL-FETAL EXCHANGE; OXIDATION-REDUCTION; PLACENTA; PREGNANCY;

EID: 19444362513     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000161412.24792.55     Document Type: Note

References (15)

1. Jones CT, Rolph TP 1985 Metabolism during fetal life: a functional assessment of metabolic development. Physiol Rev 65:357-430
2. Kaufmann P, Scheffen I 1999 Placental development. In: Polin RA, Fox F (eds) Fetal and Neonatal Physiology. WB Saunders, New York, pp 47-56
3. Rinaldo P, Matern D, Bennett MJ 2002 Fatty acid oxidation disorders. Ann Rev Physiol 64:477-502
4. Bennett MJ, Rinaldo P, Strauss AW 2000 Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 37:1-44
5. Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW 1999 A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340:1723-1731
6. Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV 1993 Pregnancy and fetal long chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Lancet 341:407-408
7. Tyni T, Ekholm E, Pihko H 1998 Pregnancy complications are frequent in long-chain 3-hydroxyacyl-CoA deficiency. Am J Obstet Gynecol 178:603-608
8. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB 2002 Evidence for fatty acid oxidation in human placenta and the relationship to fatty acid oxidation enzyme activities with gestational age. Placenta 23:447-450
9. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW 2003 Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver disease. Am J Physiol Endocrinol Metab 284:E1098-E1105
10. Oey NA, den Boer ME, Ruiter JP, Wanders RJ, Duran M, Waterham HR, Boer K, van der Post JA, Wijburg FA 2003 High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis 26:1-8
11. Oey NA, den Boer MEJ, Wijburg FA, Vekemans M, Auge J, Steiner C, Wanders RA, Waterham HR, Ruiter JP, Attie-Bitach T 2005 Long-chain fatty acid oxidation during early human development. Pediatr Res 57:755-759
12. Shekhawat P, Matern D, Strauss AW 2005 Fetal fatty acid oxidation disorders, their effects on maternal and neonatal outcome: Impact of expanded newborn screening on diagnosis and management. Pediatr Res 57 (Review Issue):78R-86R
13. Jeffery CJ 2003 Moonlighting proteins: old proteins learning new tricks. Trends Genet 19:415-417
14. Klopfenstein DR 2000 Motor protein receptors: moonlighting on other jobs. Cell 103:537-540
15. Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Hollenberg AN, Flier JS 2004 Regulated production of a peroxisome proliferators-activated receptor-γ ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem 279:36093-36102